🔊CEOInterviews

Mark Bezjak on digital health

From Zimmer Biomet: In Studio with Mark Bezjak, Joe Urban, and Joe Mullings · · Mullings Group

“With our PIQ platform, you collect data post-op and now you've got the complete continuum of care for that patient, allowing identification of what's happening through the journey—good, bad, benefits the patient, the physician, payers, and providers.”

Mark Bezjak
President of Americas, Zimmer Biomet
digital healthdata analyticspatient caremedical technology

On , Mark Bezjak, President of Americas at Zimmer Biomet, spoke about digital health during Zimmer Biomet: In Studio with Mark Bezjak, Joe Urban, and Joe Mullings on Mullings Group.

Zimmer Biomet: In Studio with Mark Bezjak, Joe Urban, and Joe Mullings
Watch on YouTube at 5:43
Zimmer Biomet: In Studio with Mark Bezjak, Joe Urban, and Joe Mullings
Mullings Group
Watch on YouTube at 5:43
Subscribe to Our Channel Here https://www.youtube.com/MullingsGroup --------------- LinkedIn: ...
Mark Bezjak

About Mark Bezjak

President of Americas · Zimmer Biomet

Mark Bezjak, President of Americas at Zimmer Biomet, appeared on a December 2024 episode of "160 Studios" hosted by Joe Mullings. During the interview, Bezjak discussed his 16-year tenure at the company, attributing his longevity to the opportunity to "differentiate musculoskeletal care" and the people and leadership at the organization. He stated that he took his current role because of CEO Ivon, citing the need to "work at that pace" and "think creatively and outside the box" to change the delivery of musculoskeletal care. Bezjak described the company's focus on advancing technology, including its PIQ platform for collecting post-operative data, and predicted a "seismic shift" in orthopedics over the next 24 to 36 months with the integration of sensored technology, interconnectivity, and predictive analytics. Bezjak noted that 20% of knee replacement patients are not satisfied with their outcomes, and he said the company's innovation is driven by understanding the patient journey from pre-operative care through rehab. He emphasized Zimmer Biomet's goal of being "the boldest medtech company" and its shift from a focus on metal and plastic implants to a solutions-based organization. Bezjak also highlighted the company's partnerships in building ambulatory surgery centers and its ability to hyperfocus on musculoskeletal health as an efficiency advantage over competitors.

Profile compiled from Mark Bezjak's verified public interviews and appearances. See all quotes & transcripts →

More from Mark Bezjak Zimmer Biomet (ZBH) Full Transcript Explore All Executives